4//SEC Filing
Whitfield Dianne C. 4
Accession 0001819790-25-000045
CIK 0001819790other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 9:39 PM ET
Size
11.6 KB
Accession
0001819790-25-000045
Insider Transaction Report
Form 4
Whitfield Dianne C.
Chief Human Resources Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-15−7,248→ 14,497 total→ Common Stock (7,248 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-15−7,175→ 21,527 total→ Common Stock (7,175 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-15−4,462→ 4,463 total→ Common Stock (4,462 underlying) - Exercise/Conversion
Common Stock
2025-03-15+18,885→ 53,066 total
Footnotes (5)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs").
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025 and 2026, subject to the Reporting Person's continuous service.
- [F4]RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service.
- [F5]RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001839516
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 9:39 PM ET
- Size
- 11.6 KB